Mar 5 |
MyMD Pharmaceuticals said it has regained compliance with Nasdaq rules
|
Mar 5 |
MyMD Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement for Continued Listing
|
Feb 13 |
MyMD Pharmaceuticals down after announcing reverse stock split
|
Feb 13 |
MyMD Pharmaceuticals Announces Reverse Stock Split to Maintain Nasdaq Listing
|
Jan 17 |
Why DatChat Shares Are Trading Lower By Around 33%; Here Are 20 Stocks Moving Premarket
|
Dec 29 |
MyMD Pharmaceuticals Releases Positive Clinical Trial Results For Sarcopenia Treatment Drug
|
Dec 13 |
Why ReShape Lifesciences Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket
|
Dec 6 |
MyMD Pharmaceuticals Plans FDA-Cleared Phase 2 Clinical Trial of MYMD-1 in Rheumatoid Arthritis
|
Oct 19 |
Five Hours Of Pain Relief? Preclinical Study Shows Promising Results With This Non-Toxic CBD
|
Oct 19 |
MyMD Announces Preclinical Study Results Showing Novel Cannabidiol Analog, Supera-CBD™, Reduced Acute Inflammatory Pain
|